Advancing Neurodegenerative Disease Management: Technical, Ethical, and Regulatory Insights from the NeuroPredict Platform
On a worldwide scale, neurodegenerative diseases, including multiple sclerosis, Parkinson’s, and Alzheimer’s, face considerable healthcare challenges demanding the development of novel approaches to early detection and efficient treatment. With its ability to provide real-time patient monitoring, cu...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Future Internet |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-5903/17/7/320 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849733917083435008 |
|---|---|
| author | Marilena Ianculescu Lidia Băjenaru Ana-Mihaela Vasilevschi Maria Gheorghe-Moisii Cristina-Gabriela Gheorghe |
| author_facet | Marilena Ianculescu Lidia Băjenaru Ana-Mihaela Vasilevschi Maria Gheorghe-Moisii Cristina-Gabriela Gheorghe |
| author_sort | Marilena Ianculescu |
| collection | DOAJ |
| description | On a worldwide scale, neurodegenerative diseases, including multiple sclerosis, Parkinson’s, and Alzheimer’s, face considerable healthcare challenges demanding the development of novel approaches to early detection and efficient treatment. With its ability to provide real-time patient monitoring, customized medical care, and advanced predictive analytics, artificial intelligence (AI) is fundamentally transforming the way healthcare is provided. Through the integration of wearable physiological sensors, motion sensors, and neurological assessment tools, the NeuroPredict platform harnesses AI and smart sensor technologies to enhance the management of specific neurodegenerative diseases. Machine learning algorithms process these data flows to find patterns that point out disease evolution. This paper covers the design and architecture of the NeuroPredict platform, stressing the ethical and regulatory requirements that guide its development. Initial development of AI algorithms for disease monitoring, technical achievements, and constant enhancements driven by early user feedback are addressed in the discussion section. To ascertain the platform’s trustworthiness and data security, it also points towards risk analysis and mitigation approaches. The NeuroPredict platform’s capability for achieving AI-driven smart healthcare solutions is highlighted, even though it is currently in the development stage. Subsequent research is expected to focus on boosting data integration, expanding AI models, and providing regulatory compliance for clinical application. The current results are based on incremental laboratory tests using simulated user roles, with no clinical patient data involved so far. This study reports an experimental technology evaluation of modular components of the NeuroPredict platform, integrating multimodal sensors and machine learning pipelines in a laboratory-based setting, with future co-design and clinical validation foreseen for a later project phase. |
| format | Article |
| id | doaj-art-db8a4819eca64836af2b18486822bdfc |
| institution | DOAJ |
| issn | 1999-5903 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Future Internet |
| spelling | doaj-art-db8a4819eca64836af2b18486822bdfc2025-08-20T03:07:55ZengMDPI AGFuture Internet1999-59032025-07-0117732010.3390/fi17070320Advancing Neurodegenerative Disease Management: Technical, Ethical, and Regulatory Insights from the NeuroPredict PlatformMarilena Ianculescu0Lidia Băjenaru1Ana-Mihaela Vasilevschi2Maria Gheorghe-Moisii3Cristina-Gabriela Gheorghe4Department of Communications, Applications, and Digital System, National Institute for Research and Development in Informatics—ICI Bucharest, 011455 Bucharest, RomaniaDepartment of Communications, Applications, and Digital System, National Institute for Research and Development in Informatics—ICI Bucharest, 011455 Bucharest, RomaniaDepartment of Communications, Applications, and Digital System, National Institute for Research and Development in Informatics—ICI Bucharest, 011455 Bucharest, RomaniaDepartment of Communications, Applications, and Digital System, National Institute for Research and Development in Informatics—ICI Bucharest, 011455 Bucharest, RomaniaDepartment of Communications, Applications, and Digital System, National Institute for Research and Development in Informatics—ICI Bucharest, 011455 Bucharest, RomaniaOn a worldwide scale, neurodegenerative diseases, including multiple sclerosis, Parkinson’s, and Alzheimer’s, face considerable healthcare challenges demanding the development of novel approaches to early detection and efficient treatment. With its ability to provide real-time patient monitoring, customized medical care, and advanced predictive analytics, artificial intelligence (AI) is fundamentally transforming the way healthcare is provided. Through the integration of wearable physiological sensors, motion sensors, and neurological assessment tools, the NeuroPredict platform harnesses AI and smart sensor technologies to enhance the management of specific neurodegenerative diseases. Machine learning algorithms process these data flows to find patterns that point out disease evolution. This paper covers the design and architecture of the NeuroPredict platform, stressing the ethical and regulatory requirements that guide its development. Initial development of AI algorithms for disease monitoring, technical achievements, and constant enhancements driven by early user feedback are addressed in the discussion section. To ascertain the platform’s trustworthiness and data security, it also points towards risk analysis and mitigation approaches. The NeuroPredict platform’s capability for achieving AI-driven smart healthcare solutions is highlighted, even though it is currently in the development stage. Subsequent research is expected to focus on boosting data integration, expanding AI models, and providing regulatory compliance for clinical application. The current results are based on incremental laboratory tests using simulated user roles, with no clinical patient data involved so far. This study reports an experimental technology evaluation of modular components of the NeuroPredict platform, integrating multimodal sensors and machine learning pipelines in a laboratory-based setting, with future co-design and clinical validation foreseen for a later project phase.https://www.mdpi.com/1999-5903/17/7/320digital health systemneurodegenerative diseasesmultimodal monitoringartificial intelligencefall detectionedge-to-cloud architecture |
| spellingShingle | Marilena Ianculescu Lidia Băjenaru Ana-Mihaela Vasilevschi Maria Gheorghe-Moisii Cristina-Gabriela Gheorghe Advancing Neurodegenerative Disease Management: Technical, Ethical, and Regulatory Insights from the NeuroPredict Platform Future Internet digital health system neurodegenerative diseases multimodal monitoring artificial intelligence fall detection edge-to-cloud architecture |
| title | Advancing Neurodegenerative Disease Management: Technical, Ethical, and Regulatory Insights from the NeuroPredict Platform |
| title_full | Advancing Neurodegenerative Disease Management: Technical, Ethical, and Regulatory Insights from the NeuroPredict Platform |
| title_fullStr | Advancing Neurodegenerative Disease Management: Technical, Ethical, and Regulatory Insights from the NeuroPredict Platform |
| title_full_unstemmed | Advancing Neurodegenerative Disease Management: Technical, Ethical, and Regulatory Insights from the NeuroPredict Platform |
| title_short | Advancing Neurodegenerative Disease Management: Technical, Ethical, and Regulatory Insights from the NeuroPredict Platform |
| title_sort | advancing neurodegenerative disease management technical ethical and regulatory insights from the neuropredict platform |
| topic | digital health system neurodegenerative diseases multimodal monitoring artificial intelligence fall detection edge-to-cloud architecture |
| url | https://www.mdpi.com/1999-5903/17/7/320 |
| work_keys_str_mv | AT marilenaianculescu advancingneurodegenerativediseasemanagementtechnicalethicalandregulatoryinsightsfromtheneuropredictplatform AT lidiabajenaru advancingneurodegenerativediseasemanagementtechnicalethicalandregulatoryinsightsfromtheneuropredictplatform AT anamihaelavasilevschi advancingneurodegenerativediseasemanagementtechnicalethicalandregulatoryinsightsfromtheneuropredictplatform AT mariagheorghemoisii advancingneurodegenerativediseasemanagementtechnicalethicalandregulatoryinsightsfromtheneuropredictplatform AT cristinagabrielagheorghe advancingneurodegenerativediseasemanagementtechnicalethicalandregulatoryinsightsfromtheneuropredictplatform |